Peptides and Proteins
Peptides are short chains of amino acids linked by peptide bonds, whereas proteins are longer and more complex amino acid chains that can adopt functional three-dimensional structures. Both types of compounds are essential for various biological functions, such as catalysing reactions (enzymes), immune defence (antibodies), and cellular signalling. Proteins have a hierarchical structure, including the amino acid sequence, secondary, tertiary, and quaternary structures. Peptides are used in pharmaceutical and cosmetic therapies due to their specific biological properties, such as in the treatment of metabolic diseases or enhancing cellular regeneration. Proteins, on the other hand, have applications in biotechnology, nutrition, and regenerative medicine.
At CymitQuimica, we offer high-purity peptides and proteins for research in biotechnology and therapeutic applications.
Found 3113 products of "Peptides and Proteins"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Dihydro Cyclosporin A
CAS:Controlled Product<p>Applications A Cyclosporin A (C988900) analog, an immunosuppressant.<br>References Emmer, G., et al.: J. Med. Chem., 37, 1918 (1994), High, K., et al.: J. Biol. Chem., 269, 9105 (1994),<br></p>Formula:C62H113N11O12Color and Shape:WhiteMolecular weight:1204.633,3',5'-Triiodo-L-thyronine
CAS:Formula:C15H12I3NO4Color and Shape:Light Beige To GreyMolecular weight:650.974-Methylbenzenesulfonic Acid Monohydrate
CAS:Controlled Product<p>Impurity Lisinopril EP Impurity B/ Anastrozole EP Impurity F<br>Applications 4-Methylbenzenesulfonic Acid Monohydrate (Lisinopril EP Impurity B) is used in the synthesis of resveratrol. Also used in the synthesis of oxane derivatives as antimalarial agents.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Davis, M. et al.: Org. Prep. Proc. Int., 45, 304 (2013); Wang, X. et al.: J. Med. Chem., 56, 2547 (2013);<br></p>Formula:C7H8O3S·H2OColor and Shape:WhiteMolecular weight:190.22(S)-Lisinopril Dimer
CAS:Controlled Product<p>Applications (S)-Lisinopril (L468985) impurity. Lisinopril Impurity G (Dimer Impurity)<br></p>Formula:C42H60N6O9Color and Shape:WhiteMolecular weight:792.96(2R,4R)-Sacubitril
CAS:<p>Applications (2R,4R)-Sacubitril is an impurity of Sacubitril (S080895) which is an antihypertensive drug used in combination with valsartan.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References McMurray, J., et al.: N. Eng. J. Med., 371 (2014);<br></p>Formula:C24H29NO5Color and Shape:NeatMolecular weight:411.491Romidepsin
CAS:Controlled Product<p>Applications Romidepsin is a histone deacetylase inhibitor that can alter chromatin structure and gene transcription leading to multiple changes in cellular protein production. This may result in cell cycle arrest and tumor growth inhibition. Romidepsin has shown anti-proliferative activity in vitro against multiple mouse and human tumor cell lines and in vivo in human tumor xenograft models. Romidepsin can be administered with a second agent, such as a cytotoxic agent, a steroidal agent, a proteasome inhibitor, or a kinase inhibitor.<br>References Ueda, H., et al.: J. Antibiot., 47, 301 (1994), Weidle, U., et al.: Anticancer Res., 20, 1471 (2000), Kitazono, M., et al.: Cancer Res., 61, 6328 (2001), Sandor, V., et al.: Clin. Cancer Res., 8, 718 (2002),<br></p>Formula:C24H36N4O6S2Color and Shape:White To Off-WhiteMolecular weight:540.70Voclosporin-d4
CAS:Controlled Product<p>Applications Labelled Voclosporin (V678500). A new agent for the treatment of noninfectious uveitis. Uveitis is an inflammatory, putative Th1-mediated autoimmune disease that affects various parts of the eye and is a leading cause of visual loss. Voclosporin, a rationally designed novel calcineurin inhibitor, exhibits a favorable safety profile, a strong correlation between pharmacokinetic and pharmacodynamic response, and a wide therapeutic window. Immunosuppressant.<br>References Aspeslet, L., et al.: Transplant Proc., 33, 1048 (2001), Cho, M., et al.: Arthritis Rheum., 46, 1202 (2002), Staatz, C., et al.: Clin. Pharmacokinet., 43, 623 (2004),<br></p>Formula:C63H107D4N11O12Color and Shape:NeatMolecular weight:1218.65(S)-Lisinopril-d5 Sodium
CAS:Controlled ProductFormula:C21H26D5N3NaO5Color and Shape:NeatMolecular weight:433.51DL-Methionyl-DL-methionine
CAS:Controlled ProductFormula:C10H20N2O3S2Color and Shape:NeatMolecular weight:280.4Bortezomib
CAS:Controlled Product<p>Stability Hygroscopic and Moisture Sensitive<br>Applications Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);<br></p>Formula:C19H25BN4O4Color and Shape:White To Off-WhiteMolecular weight:384.24L-Prolinamide
CAS:<p>Applications Proline based organocatalyst.<br>References Alberg, D., et al.: Bioorg. Med. Chem. Lett., 19, 3888 (2009), Huang, X., et al.: J. Phys. Chem., 114, 1068 (2010),<br></p>Formula:C5H10N2OColor and Shape:White SolidMolecular weight:114.146(R)-Hydroxy Des(boric Acid) Bortezomib
CAS:Controlled Product<p>Impurity Bortezomib USP Impurity I<br>Applications (R)-Hydroxy Des(boric acid) Bortezomib is an impurity in the synthesis of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C. et al.: Chem. and Eng. News, 87, 41 (2009)<br></p>Formula:C19H24N4O3Color and Shape:NeatMolecular weight:356.42Perfluorophenol
CAS:Controlled Product<p>Applications Perfluorophenol is used in the synthesis of PGA-films as biodegradable polymers. It also participates in the synthesis of tripod macrocyclic Gd(III) chelates for cancer molecular MRI.<br>References Lee, K. et al.: Langmuir., 20, 2531 (2004); Zhou, Z. et al.: Biomater., 34, 7683 (2013);<br></p>Formula:C6HF5OColor and Shape:NeatMolecular weight:184.06GSK1904529A
CAS:<p>GSK1904529A (GSK 4529) is a specific inhibitor of IGF-1R (IC50=27 nM) and IR(IC50=25 nM) .</p>Formula:C44H47F2N9O5SPurity:98.2% - 99.38%Color and Shape:SolidMolecular weight:851.96(4R)-1-Methyl-4-propyl-L-proline Hydrochloride
CAS:Controlled Product<p>Applications Proline derivative, and an intermediate in the production of biosynthetic antibiotics.<br></p>Formula:C9H17NO2·ClHColor and Shape:NeatMolecular weight:207.70Lopinavir Metabolite M-1
CAS:Controlled Product<p>Applications A major metabolite of Lopinavir (L469480) . It is a COVID19-related research product.<br>References Molla, A., et al.: J. Virology, 250, 255 (1998), Sham, H., et al.: Antimicrob. Agents Chemother., 42, 3218 (1998), Kumar, G., et al.: Drug Metab. Dispos., 27, 86 (1999),<br></p>Formula:C37H46N4O6Color and Shape:NeatMolecular weight:642.78L-Valine-d8
CAS:Controlled Product<p>Applications Labelled analogue of L-Vailne. L-Valine is an essential amino acid and one of 20 proteinogenic amino acids. L-Valine cannot be manufactured by the body and must be acquired through diet or supplementation. L-valine is found in grains, dairy products, mushrooms, meats, peanuts and soy proteins. L-Valine has been used in studies to attenuate arrhythmias and induce hypotensive effects.<br>References Choi, C.W. et al.: Anim. Feed Sci. Technol., 102, 15 (2002); Kolarski, D. et al.: Krmiva, 30, 155 (1988); Oba, M. et al.: J. Dairy Sci., 93, 2044 (2010); Mitrega, K. et al.: Pharmacol. Res., 64, 218 (2011);<br></p>Formula:C52H8H3NO2Color and Shape:NeatMolecular weight:125.20Desisobutyl-n-butyl Bortezomib
CAS:<p>Impurity Bortezomib N-Pentyl Impurity<br>Applications Desisobutyl-n-butyl Bortezomib is an impurity of Bortezomib (B675700). Bortezomib impurity 5.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Lin, G., et al.: J. Biol. Chem., 283, 34423 (2008);<br></p>Formula:C19H25BN4O4Color and Shape:NeatMolecular weight:384.24N-Nitroso Lisinopril
CAS:Formula:C21H30N4O6Color and Shape:White To Light YellowMolecular weight:434.486TD-165
CAS:<p>TD-165, a PROTAC-based cereblon (CRBN) degrader, consists of a cereblon (CRBN) ligand-binding group, a linker, and a von Hippel-Landau (VHL) binding group[1].</p>Formula:C46H59N7O8SPurity:99.24%Color and Shape:SolidMolecular weight:870.07L-Methionine
CAS:<p>Applications Essential aminoacid for human development. Hepatoprotectant; antidote (acetominophen poisoning); urinary acidifier.<br>References Benevenga, N.J., et al.: J. Agric. Food Chem., 22, 2 (1974), Fleisher, L.D., et al.: Clin. Endocrinol. Metab., 3, 37 (1974), Meinnel, T., et al.: Biochimie, 75, 1061 (1993),<br></p>Formula:C5H11NO2SColor and Shape:White To Off-WhiteMolecular weight:149.21MK 677
CAS:<p>Applications MK-677 is a potent, non-peptide ghrelin receptor agonist.<br>References Kirstie, A., et al.: Mol. Pharmacol., 76, 802 (2009); Birgitte, H. et al.: Mol. Pharmacol., 75, 44 (2009)<br></p>Formula:C27H36N4O5S·CH4SO3Color and Shape:NeatMolecular weight:624.80Protoporphyrin-9
CAS:<p>Stability Light Sensitive<br>Applications Protoporphyrin-9 is the precursor to heme sites and chlorophyll.<br></p>Formula:C34H34N4O4Color and Shape:NeatMolecular weight:562.66N,N-Dimethyl-4-hydroxymethoxy Clomiphene (~90%, contains ~10% Z-isomer)
CAS:Controlled ProductFormula:C25H26ClNO3Color and Shape:NeatMolecular weight:423.935-9-Leuprolide xTFA Salt
CAS:Controlled Product<p>Applications 5-9-Leuprolide is a metabolite of Leuprolide (L330590), a gonadotropin-releasing hormone (GnRH) analogue acting as an agonist at pituitary GnRH receptors.<br>References Handelsman, David J., et al.: J. of Steroid Biochem. and Mol. Bio., 141, 113-120 (2014);Okada, Hiroaki, et al.: Pharma. Res., 8(6), 787-91 (1991)<br></p>Formula:C34H57N9O6·x(C2HF3O2)Color and Shape:NeatMolecular weight:687.87+ x(114.02)Tabimorelin
CAS:Controlled Product<p>Applications NN703 (Tabimorelin) is an orally active growth hormone (GH) secretagogue intended for use as an alternative to daily injections of GH. In vitro studies in human liver microsomes have indicated that NN703 is a mechanism-based inhibitor of CYP3A4.<br>References Fabre, G., et al.: Biochem. Pharmacol., 37, 4389 (1988), Thummel, K., et al.: Clin. Pharmacol. Ther., 59, 491 (1996), Yu, D., et al.: J. Clin. Pharmacol., 39, 1203 (1999),<br></p>Formula:C32H40N4O3Color and Shape:NeatMolecular weight:528.68Lisinopril Cyclohexyl Analogue
CAS:Controlled Product<p>Impurity Lisinopril EP Impurity F<br>Applications Lisinopril Cyclohexyl Analogue (Lisinopril EP Impurity F) is a Lisinopril (L468985) impurity.<br>References Paraskevas, G., et al.: J. Pharm. Biomed. Anal., 29, 865 (2002),<br></p>Formula:C21H37N3O5Color and Shape:NeatMolecular weight:411.54N-[(1S)-2-Amino-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide
CAS:<p>Impurity Bortezomib USP Impurity B<br>Applications N-[(1S)-2-Amino-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide is a metabolite of Bortezomib (B675700), a proteasome inhibitor for the treatment of multiple myeloma and is known to also target the ubiquitin-proteasome pathway.<br>References Pekol, T., et al.: Drug. Meta. Disp., 33, 771 (2005); Hsieh, F.Y., et al.: J. Pharma. Biomed. Anal., 49, 115 (2009);<br></p>Formula:C14H14N4O2Color and Shape:NeatMolecular weight:270.29Teduglutide
CAS:<p>Teduglutide (ALX-0600) is a glucagon-like peptide-2 analog that increases intestinal absorption and can be used in research on short bowel syndrome (SBS).</p>Formula:C164H252N44O55SPurity:98.08%Color and Shape:SolidMolecular weight:3752.08Bortezomib-D8 (Major)
CAS:Controlled Product<p>Applications Labelled Bortezomib, which the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells.d6-3%d7-10%d8-86%<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005)<br></p>Formula:C19H17D8BN4O4Color and Shape:Off-WhiteMolecular weight:392.29N-Glycylproline
CAS:<p>Applications N-Glycylproline was found to exhibit anti-ischemic effects on the metabolism of neuroactive amino acids and indices of energy turnover in the neocortex of rats after experimental brain ischemia.<br>References Bashun, Z.N., et al.: Neurochem. J., 7, 39 (2013);<br></p>Formula:C7H12N2O3Color and Shape:NeatMolecular weight:172.182(R)-3-Carboxy-2-hydroxy-N,N,N-trimethylpropan-1-aminium Chloride
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications (R)-3-Carboxy-2-hydroxy-N,N,N-trimethylpropan-1-aminium chloride is an important co-factor of mammalian mitochondrial energy metabolism. It is also a good active ingredient for dry-skin.<br>References Geier, David A., et al.: Neurochem. Res., 38(11), 2336-2341 (2013);Tanno, Osamu, et al.: Fragrance J., 33(8), 82-85 (2005);<br></p>Formula:C7H16NO3·ClColor and Shape:White To Off-WhiteMolecular weight:197.660(S)-2-((S)-4-Methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoic Acid
CAS:Controlled Product<p>Applications (S)-2-((S)-4-Methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoic Acid is an intermediate for Carfilzomib (C183460), which is a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.<br>References Fostier, K., et al.: Oncotargets. Therap., 5, 237 (2012); Geurink, P.P., et al.: J. Med. Chem., 56, 1262 (2013); McCormack, P.L., et al.: Drugs., 72, 2023 (2012);<br></p>Formula:C31H42N4O6Color and Shape:NeatMolecular weight:566.69Desethyl Sacubitril-d4
CAS:Controlled ProductFormula:C22H21D4NO5Color and Shape:NeatMolecular weight:387.46Oxytocin-d5 Trifluoroacetate
CAS:Controlled Product<p>Applications Labelled Oxytocin. The principal uterus-contracting and lactation-stimulating hormone of the posterior pituitary gland.<br>References Pierce, et al.: J. Biol. Chem., 199, 929 (1952), Tuppy, et al.: Biochem. Biophys. Acta, 11, 449 (1953), Cash, et al.: J. Med. Pharm. Chem., 5, 413 (1962), Nachtmann, F., et al.: Anal. Profiles Drug Subs., 10, 563 (1981),<br></p>Formula:C45H62D5F3N12O14S2Color and Shape:White To Off-WhiteMolecular weight:1126.24Glecaprevir
CAS:Controlled Product<p>Applications Glecaprevir is an antiviral drug used in the treatment of patients with hepatitis C virus (HCV) genotype 1-6, of special interest for the treatment of patients with chronic kidney disease also suffering from HCV.<br>References Kwo, P., et. al.: J. Hepatol, 67, 263 (2017)Gane, E., et. al.: N. Engl. J. Med, 377, 1448 (2017)<br></p>Formula:C38H46F4N6O9SColor and Shape:NeatMolecular weight:838.86Sacubitril Sodium Salt
CAS:Formula:C24H28NO5·NaColor and Shape:White To Off-WhiteMolecular weight:433.473(1R,3S)-Camphoric Acid
CAS:<p>Applications (1R,3S)-Camphoric Acid is used primarily as a reagent in syntheses of crystalline structures. It is used in the preparation of polymeric transition metal dipyridylamine D-camphorate complexes.<br>References Blake, K. et al.: Crys. Growth Des., 12, 5215 (2012);<br></p>Formula:C10H16O4Color and Shape:White SolidMolecular weight:200.23Cyclosporin C
CAS:Controlled Product<p>Applications A group of nonpolar cyclic oligopeptides with immunosupppressant activity.<br>References van Wartburg, A., et al.: Prog. Med. Chem., 25, 1 (1988), Jorgensen, K.A., et al.: Scand. J. Imunol., 57, 93 (2003), Vollenbroeker, et al.: Transplant. Proc., 37, 1741 (2005),<br></p>Formula:C62H111N11O13Purity:>80%Color and Shape:NeatMolecular weight:1218.61(S)-Tetrahydro-α-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetic Acid
CAS:Controlled ProductFormula:C9H16N2O3Color and Shape:NeatMolecular weight:200.23L-Methionine-34S
CAS:<p>Applications Labelled L-Methionine, an essential aminoacid for human development. Hepatoprotectant; antidote (acetominophen poisoning); urinary acidifier.<br>References Benevenga, N.J., et al.: J. Agric. Food Chem., 22, 2 (1974), Fleisher, L.D., et al.: Clin. Endocrinol. Metab., 3, 37 (1974), Meinnel, T., et al.: Biochimie, 75, 1061 (1993),<br></p>Formula:C5H11NO234SColor and Shape:NeatMolecular weight:151.11N-2-(Hydroxyethyl)-L-valine-d4 (Technical grade)
CAS:Controlled Product<p>Applications Labelled N-2-(Hydroxyethyl)-L-valine (H942300). Cotinine and N-(2-hydroxyethyl)valine are markers of passive exposure to tobacco smoke in children.<br>References Dempsey, D., et al.: Clin. Pharmacol. Ther., 67, 458 (2000), Smith, C., et al.: Food Chem. Toxicol., 41, 807 (20030,<br></p>Formula:C7H11D4NO3Color and Shape:WhiteMolecular weight:165.22Carfilzomib (2S,4R)-Diol
Controlled Product<p>Applications Carfilzomib (2S,4R)-Diol is a derivative of Carflizomib (C183460), a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.<br>References Fostier, K., et al.: Oncotargets. Therap., 5, 237 (2012); Geurink, P.P., et al.: J. Med. Chem., 56, 1262 (2013); McCormack, P.L., et al.: Drugs., 72, 2023 (2012);<br></p>Formula:C40H59N5O8Color and Shape:NeatMolecular weight:737.93Sacubitril Calcium
CAS:<p>Applications Sacubitril is an antihypertensive drug used in combination with valsartan. The combination drug, valsartan/sacubitril, known during trials as LCZ696 and marketed under the brand name, Entresto, is a treatment for heart failure.<br>References McMurray, J., et al.: N. Eng. J. Med., 371 (2014)<br></p>Formula:C24H28NOCa2Color and Shape:NeatMolecular weight:430.52rhPTH (1-30) Trifluoroacetic Acid Salt Hydrate
Controlled Product<p>Impurity Teriparatide Impurity<br>Applications A fragment of human parathyroid hormone (hPTH) peptide sequence containing the 30 N-terminal residues of hPTH.<br>References Niall, et al.: Proc. Natl. Acad. Sci., 71, 384 (1974);<br></p>Formula:C157H260N48O46S2•x(C2HF3O2)•y(H2O)Color and Shape:NeatMolecular weight:3620.171140218(1R,2R)-Bortezomib
CAS:<p>Impurity Bortezomib USP Related Compound A<br>Applications (1R,2R)-Bortezomib is a diastereomer of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009)<br></p>Formula:C19H25BN4O4Purity:>85%Color and Shape:NeatMolecular weight:384.244-(Phenylamino]-1-benzyl-4-piperidinecarboxylic Acid Methyl Ester
CAS:Controlled Product<p>Applications Remifentanil derivative.<br>References James, M.K., et al.: J. Pharmacol. Exp. Ther., 259, 712 (1991), Hoffman, W.E., et al.: Anesthesiology, 79, 107 (1993), Selinger, K., et al.: J. Pharm. Biomed. Anal., 12, 243 (1994), Richardson, T.D., et al.: Expert Opin. Drug Saf., 4, 643 (2005),<br></p>Formula:C20H24N2O2Color and Shape:NeatMolecular weight:324.4168(R)-Lisinopril Sodium Salt
CAS:<p>Applications R,S,S-Isomer of Lisinopril (L468985).<br>References Goa, K.L., et al.: Drugs, 52, 564 (1996), Chaturvedi, N., et al.: Lancet, 351, 28 (1998)<br></p>Formula:C21H31N3NaO5Color and Shape:NeatMolecular weight:428.48(R)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid
CAS:Controlled Product<p>Applications (R)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid, is an amino acid building block used in peptide synthesis. With a growing peptide drug market the fast, reliable synthesis of peptides is of great importance.<br></p>Formula:C10H11NO2Color and Shape:NeatMolecular weight:177.20Semaglutide Impurity 51 (D-Thr 7)
<p>D-Thr(7)-Semaglutide is a semaglutide impurity. The amino acid at position 7 has been replaced by the D-form of the amino acid D-threonine (D-Thr). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Formula:C187H291N45O59Molecular weight:4,113.64 g/molSemaglutide Impurity 56 (D-Glu 21)
<p>D-Glu(21)-Semaglutide is a semaglutide impurity. The amino acid at position 21 has been replaced by the D-form of the amino acid D-glutamic acid (D-Glu). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Formula:C187H291N45O59Molecular weight:4,113.64 g/molSemaglutide Impurity 59
<p>D-Arg(28)-Semaglutide is a semaglutide impurity. The amino acid at position 28 has been replaced by the D-form of the amino acid D-arginine (D-Arg). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Formula:C187H291N45O59Molecular weight:4,113.64 g/mol(S,E)-N-(1-(3-Methylbut-1-enylamino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide
CAS:<p>R-N-(1-(3-methylbut-1-enyl)-1-oxo-3-phenylpropan-2-yl) pyrazine-2-carboxamide is a drug product that is used for the treatment of bacterial infections. The compound is an impurity in the synthesis of other compounds and is also used as an analytical standard. It is synthesized from commercially available starting materials and through custom synthesis. R-N-(1-(3-methylbut-1-enyl)-1--oxo--3--phenylpropan--2--yl)pyrazine--2--carboxamide has been shown to be metabolized by CYP450 enzymes, which are responsible for the metabolism of many drugs. R-(1-(3Methylbut 1Enylamino)-1Oxo 3Phenylpropan 2Yl)Pyrazine 2Carboxamide has not been evaluated as a drug product and therefore does not</p>Formula:C19H22N4O2Purity:Min. 95%Molecular weight:338.4 g/molSemaglutide Impurity 60 (D-Arg 30)
<p>D-Arg(30)-Semaglutide is a semaglutide impurity. The amino acid at position 30 has been replaced by the D-form of the amino acid D-arginine (D-Arg). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Formula:C187H291N45O59Molecular weight:4,113.64 g/molD-Thr(5)-Semaglutide
<p>D-Thr(5)-Semaglutide is a semaglutide impurity. The amino acid at position 5 has been replaced by the D-form of the amino acid D-threonine (D-Thr). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Formula:C187H291N45O59Molecular weight:4,113.64 g/molDes-His(1)-Semaglutide
<p>Des-His(1)-semaglutide is a semaglutide-related impurity. This des-amino acid form has the histidine (His) amino acid from position 1 removed from the peptide chain. Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist used for managing type 2 diabetes and obesity.</p>Formula:C181H284N42O58Molecular weight:3,976.5 g/molD-Val(10)-Semaglutide
<p>D-Val(10)-Semaglutide is a semaglutide impurity. The amino acid at position 10 has been replaced by the D-form of the amino acid D-valine (D-Val). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Formula:C187H291N45O59Molecular weight:4,113.64 g/molLisinopril EP Impurity E
CAS:<p>Lisinopril EP Impurity E is an impurity of lisinopril, which is a prescription drug used to treat high blood pressure. This impurity was found in a preparative high performance liquid chromatography (HPLC) and mass spectroscopy analysis of the drug. The molecular weight of Lisinopril EP Impurity E was determined to be 317.2 amu, which corresponds to the molecular formula C7H13NO2. The FT-IR spectrum showed that this impurity has an ammonium group at 1859 cm-1 and butanoic acid at 1647 cm-1.</p>Formula:C21H31N3O5Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:405.49 g/molLinear Semaglutide
<p>Linear semaglutide, or simply L-Sema, is the semaglutide compound without the lipid side chain modification. It is essentially a linear version of the peptide.</p>Formula:C152H230N42O47Molecular weight:3,397.76 g/molD-Ser(11)-Semaglutide
<p>D-Ser(11)-Semaglutide is a semaglutide impurity. The amino acid at position 11 has been replaced by the D-form of the amino acid D-serine (D-Ser). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Formula:C187H291N45O59Molecular weight:4,113.64 g/molD-Ala-(19)-Semaglutide
<p>D-Ala(19)-Semaglutide is a semaglutide impurity. The amino acid at position 19 has been replaced by the D-form of the amino acid D-alanine (D-Ala). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Formula:C187H291N45O59Molecular weight:4,113.64 g/molSemaglutide Impurity 101 (D-Glu 3)
<p>D-Glu(3)-Semaglutide is a semaglutide impurity. The amino acid at position 3 has been replaced by the D-form of the amino acid D-glutamic acid (D-Glu). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Formula:C187H291N45O59Molecular weight:4,113.64 g/molDes-Glu(3)-Semaglutide
<p>Des-Glu(3)-semaglutide is a semaglutide-related impurity. This des-amino acid form has got the glutamic acid or glutamate (Glu) amino acid from position 3 removed from the peptide chain. Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist used for managing type 2 diabetes and obesity.</p>Formula:C182H284N44O56Molecular weight:3,984.53 g/molBortezomib intermediate I
CAS:<p>Bortezomib intermediate I is a metabolite of bortezomib, which is a research and development drug product. Bortezomib intermediate I is an impurity standard for bortezomib. Bortezomib intermediate I can be synthesized from the corresponding compound. It is an analytical standard used in pharmacopoeia and can be used as an API impurity or synthetic material in drug development. Bortezomib intermediate I has a high purity, natural origin, and a niche application. CAS No. 1248339-44-7</p>Formula:C25H36BN5O4Purity:Min. 95%Color and Shape:White PowderMolecular weight:481.4 g/molSemaglutide Impurity 54 (D-Ala 18)
<p>D-Ala(18)-Semaglutide is a semaglutide impurity. The amino acid at position 18 has been replaced by the D-form of the amino acid D-alanine (D-Ala). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Formula:C187H291N45O59Molecular weight:4,113.64 g/molD-Asp(9)-Semaglutide
<p>D-Asp(9)-Semaglutide is a semaglutide impurity. The amino acid at position 9 has been replaced by the D-form of the amino acid D-aspartic acid (D-Asp). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Formula:C187H291N45O59Molecular weight:4,113.64 g/mol(R)-3-Methyl-1-(pyrazine- 2-carboxamido)butylboronic acid
<p>The compound is a drug product, analytical, and research material. The molecule has been synthesized and purified by the company's chemists. It is not an API impurity but an impurity standard for HPLC. This compound is a synthetic chemical that does not occur naturally in any living organism. It has been developed for use in drug development and research. The compound was custom synthesized by the company's chemists to meet customer demand for high purity standards of this compound. It is used as a pharmacopoeia standard for HPLC analysis and drug development.</p>Purity:Min. 95%D-Phe(6)-Semaglutide
<p>D-Phe(6)-Semaglutide is a semaglutide impurity. The amino acid at position 6 has been replaced by the D-form of the amino acid D-phenylalanine (D-Phe). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Formula:C187H291N45O59Molecular weight:4,113.64 g/mol3,3',5,5'-Tetraiodothyroformic acid
CAS:<p>Cymit Quimicaetic beta-D-glucosiduronic acid</p>Formula:C13H6I4O4Purity:Min. 95 Area-%Color and Shape:Off-White PowderMolecular weight:733.8 g/molD-Ala(24)-Semaglutide
<p>D-Ala(24)-Semaglutide is a semaglutide impurity. The amino acid at position 24 has been replaced by the D-form of the amino acid D-alanine (D-Ala). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Formula:C187H291N45O59Molecular weight:4,113.64 g/molD-His(1)-Semaglutide
<p>D-His(1)-Semaglutide is a semaglutide impurity. The amino acid at position 1 has been replaced by the D-form of the amino acid D-histidine (D-His). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Formula:C187H291N45O59Molecular weight:4,113.64 g/molD-Ser(8)-Semaglutide
<p>D-Ser(8)-Semaglutide is a semaglutide impurity. The amino acid at position 8 has been replaced by the D-form of the amino acid D-serine (D-Ser). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Formula:C187H291N45O59Molecular weight:4,113.64 g/molSemaglutide Impurity 29 (β-Asp-9)
<p>Beta-Asp-(9)-Semaglutide is a semaglutide impurity. The amino acid at position 9 has been replaced by the beta-aspartic acid (also known as isoaspartic, isoAsp, β-Asp or beta-Asp). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Formula:C187H291N45O59Molecular weight:4,113.64 g/molD-Ser-(12)-Semaglutide
<p>D-Ser(12)-Semaglutide is a semaglutide impurity. The amino acid at position 12 has been replaced by the D-form of the amino acid D-serine (D-Ser). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Formula:C187H291N45O59Molecular weight:4,113.64 g/molLisinopril
CAS:<p>Lisinopril, an ACE inhibitor, treats hypertension, heart failure, heart attacks, and prevents diabetes-related eye and kidney issues.</p>Formula:C21H31N3O5Purity:97.59% - 99.34%Color and Shape:SolidMolecular weight:405.49(1S,2S)-Bortezomib
CAS:Controlled Product<p>Impurity Bortezomib USP Impurity G<br>Stability Hygroscopic<br>Applications (1S,2S)-Bortezomib is an isomer of Bortezomib (B675700), proteasome inhibitor. (1S,2S)-Bortezomib has been seen to inhibit serine proteases shown to lower cellular Aβ concentrations, associated with Alzheimer’s or hypertension.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Hardy, J. et al.: Science, 297, 353 (2002); Paris, D. et al.: Mol. Med. 17, 149 (2011);<br></p>Formula:C19H25BN4O4Color and Shape:NeatMolecular weight:384.24(S)-(-)-α-Methylbenzylamine
CAS:Controlled Product<p>Applications (S)-(-)-α-Methylbenzylamine (cas# 2627-86-3) is a compound useful in organic synthesis.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br></p>Formula:C8H11NColor and Shape:NeatMolecular weight:121.184-(Phenylamino)-1-benzyl-4-piperidinecarboxamide
CAS:Controlled Product<p>Applications Used as modulators of muscarinic receptors for treatment of CNS disorders.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Coghlan, M., et al.: J. Med. Chem., 44, 1627 (2001), Ashcroft, F., et al.: J. Clin. Invest., 115, 2047 (2005), Bryan, J., et al.: Curr. Pharm. Des., 11, 2699 (2005),<br></p>Formula:C19H23N3OColor and Shape:NeatMolecular weight:309.41(2,6-Dimethylphenoxy)acetic Acid
CAS:Controlled ProductFormula:C10H12O3Color and Shape:NeatMolecular weight:180.20Semaglutide impurity
CAS:<p>Lipid chain (stearic bi-acid) plus γ-glutamic acid or glutamate (γ-Glu) amino acid.</p>Formula:C35H63N3O13Molecular weight:733.89 g/molAlamethicin
CAS:<p>Alamethicin is isolated from Trichoderma viride. It is a channel-forming peptide antibiotic and induces voltage-gated conductance in model and cell membranes.</p>Formula:C92H150N22O25Purity:98%Color and Shape:SolidMolecular weight:1964.31CP5V
CAS:<p>CP5V, a PROTAC, degrades Cdc20, halts mitosis, and inhibits cancer growth by targeting it for VHL-mediated ubiquitination and proteasome destruction.</p>Formula:C46H66Cl3N9O12SPurity:98%Color and Shape:SolidMolecular weight:1075.49(alphaS)-α-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-benzenepropanamide Monohydrochloride
CAS:Controlled Product<p>Applications (αS)-α-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-benzenepropanamide Monohydrochloride is a Bortezomib (B675700) intermediate which is used in the evaluation of bone-targeted proteasome inhibitors for myeloma.<br>References Agyin, J.K., et al.: Bioorg. Med. Chem. Lett., 23, 6455 (2013); Traenckner, E., et al.: EMBO. J., 13, 5433 (1994)<br></p>Formula:C24H37BN2O3·ClHColor and Shape:NeatMolecular weight:448.8341Daptomycin Impurity B1-I
<p>Applications Daptomycin Impurity B1-1 is an impurity of Daptomycin (D193350), cyclic lipopeptide antibiotic derived from a fermentation product of Streptomyces roseosporus; disrupts plasma membrane function in gram-positive bacteria. Antibacterial.<br>References Allen, N.E., et al.: Antimicrob. Agents Chemother., 31, 1093 (1987), Tully, F.P., et al.: Expert Opin. Invest. Drugs, 8, 1223 (1999),<br></p>Formula:C44H66N10O15•(C2HF3O2)Color and Shape:Off White SolidMolecular weight:975.0511402N-(1-Carboxy-3-phenylpropyl)-S-lisinopril (Mixture of diastereomers)
CAS:Controlled Product<p>Applications N-(1-Carboxy-3-phenylpropyl)-S-lisinopril (Mixture of diastereomers) is an impurity of lisinopril (L468985), an orally active angiotensin-converting enzyme (ACE) inhibitor.<br>References Shinde, V., et. al.: J. Pharm. Biomed. Anal., 43, 381 (2007); Goa, K.L., et al.: Drugs, 52, 564 (1996), Chaturvedi, N., et al.: Lancet, 351, 28 (1998)<br></p>Formula:C31H41N3O7Color and Shape:NeatMolecular weight:567.67Linear Daptomycin Hydrochloride Salt
CAS:<p>Applications Linear Daptomycin Hydrochloride Salt is the hydrochloride salt of L466470, which is the open-conformation of Daptomycin (D193350), cyclic lipopeptide antibiotic derived from a fermentation product of Streptomyces roseosporus; disrupts plasma membrane function in gram-positive bacteria. Antibacterial. Daptomycin Impurity<br>References Allen, N.E., et al.: Antimicrob. Agents Chemother., 31, 1093 (1987), Tully, F.P., et al.: Expert Opin. Invest. Drugs, 8, 1223 (1999),<br></p>Formula:C72H103N17O27·x(ClH)Purity:~80%Color and Shape:NeatMolecular weight:1638.69 + x(36.46)Dodecyl Polyoxyethylene (23) Aldehyde
CAS:Controlled Product<p>Applications Polyoxyethylene (23) Lauric Acid is an intermediate in the synthesis of Bril L-23 Proline (LIFETC1), a polyethylene glycol derivative of Proline (P755995), an amino acid and precursor (with vitamin C) for collagen, the building block of the structure of tendons, ligaments, arteries, veins and muscles.<br>References Bondarenko, L.B., et al.: Int. J. Peptides., 2, 1687 (2012); Rimer, T., et al.: Biomacromolecules, 13, 2110 (2012);<br></p>Formula:C14H28O2(C2H4O)nColor and Shape:Neat(2S)-1-Nitrosopyrrolidine-2-carboxamide
CAS:Controlled ProductFormula:C5H9N3O2Color and Shape:NeatMolecular weight:143.14Teriparatide-d10
CAS:Controlled ProductFormula:C181D10H281N55O51S2Color and Shape:NeatMolecular weight:4127.72Lopinavir Metabolite M-3/M-4
CAS:Controlled Product<p>Applications A major metabolite of Lopinavir (L469480) . It is a COVID19-related research product.<br>References Molla, A., et al.: J. Virology, 250, 255 (1998), Sham, H., et al.: Antimicrob. Agents Chemother., 42, 3218 (1998), Kumar, G., et al.: Drug Metab. Dispos., 27, 86 (1999),<br></p>Formula:C37H48N4O6Color and Shape:NeatMolecular weight:644.80(D-His2)-Leuprolide Trifluoroacetic Acid Salt
CAS:Controlled Product<p>Impurity Leuprolide Acetate EP Impurity B TFA salt<br>Applications Synthetic nonapeptide agonist analog of LH-RH. Antineoplastic (hormonal).<br>References Vilchez-Martinez, J.A., et al.: Biochem. Biophys. Res. Commun., 59, 1226 (1974), Sennello, L.T., et al.: J. Pharm. Sci., et al.: 75, 158 (1986), Wheeler, J.M., et al.: Am.J. Obstet. Gynecol., 167, 1367 (1992), Eri, L.M., et al.: J. Urol., 150, 359 (1993),<br></p>Formula:C59H84N16O12·x(C2HF3O2)Color and Shape:NeatMolecular weight:1209.398Boceprevir-d9
CAS:Controlled Product<p>Applications A labelled NS3 serine protease inhibitor of hepatitis C virus. It is a COVID19-related research product.<br>References Malcolm, B., et al.: Antimicrob. Agents Chemother., 50, 1013 (2006); Cubero, M., et al.: Virology, 370, 237 (2008); Venkatraman, S., et al.: J. Med. Chem., 49, 6074 (2006);<br></p>Formula:C272H9H36N5O5Color and Shape:NeatMolecular weight:528.73(S)-N-[1-(3-Hydroxy-3-methylbutanamido)-1-oxo-3-phenylpropan-2yl]pyrazine-2-carboxamide
Controlled ProductFormula:C19H22N4O4Color and Shape:NeatMolecular weight:370.49-(2,5-d|-Dioxo-L-3-amino-1-pyrrolidineacetic acid)-10-deglycine Daptomycin
CAS:Controlled Product<p>Applications 9-(2,5-d|Dioxo-L-3-amino-1-pyrrolidineacetic acid)-10-deglycine Daptomycin is a stereoisomer of Daptomycin (D193350), cyclic lipopeptide antibiotic derived from a fermentation product of Streptomyces roseosporus; disrupts plasma membrane function in gram-positive bacteria. Antibacterial.<br>References Allen, N.E., et al.: Antimicrob. Agents Chemother., 31, 1093 (1987), Tully, F.P., et al.: Expert Opin. Invest. Drugs, 8, 1223 (1999),<br></p>Formula:C72H99N17O25Color and Shape:NeatMolecular weight:1602.66Voclosporin M1 (IM1-Diol-1) metabolite
Formula:C63H113N11O14Purity:>85%Color and Shape:NeatMolecular weight:1248.66(S)-4-Oxo-homophenylalanine Hydrochloride
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications (S)-4-Oxo-homophenylalanine Hydrochloride is a derivative of L-Homophenylalanine (H600500); an antitumor agent.<br>References Brunner, Henri., et al.: Eur. J. Med. Chem., 25, 35 (1990)<br></p>Formula:C10H12ClNO3Color and Shape:NeatMolecular weight:229.66(S)-Hydroxy Des(boric Acid) Bortezomib
CAS:Controlled Product<p>Impurity Bortezomib USP Impurity J<br>Applications (S)-Hydroxy Des(boric Acid) Bortezomib is an impurity in the synthesis of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl, C. et al.: Chem. and Eng. News, 87, 41 (2009)<br></p>Formula:C19H24N4O3Color and Shape:NeatMolecular weight:356.42Lysipressin Acetic Acid Salt
CAS:<p>Applications Lysipressin Acetic Acid Salt, is an analog of Vasopressin (A769550), a powerful vasopressor used to modulate blood pressure. An endogenous antidiuretic hormone in most mammalian species. It is released into the blood from nerve terminals in the posterior pituitary and median eminence. It is a neurotransmitter in the central nervous system and also implicated in a variety of physiological processes such as regulating water balance by antidiuretic action.<br>References Yamashita, K. et al.: Mol. Phylo., 67, 520 (2013); Hua F. et al.: J. Emerg. Med., 44, 434 (2013); Perucca, J. et al.: J. AM. Soc. Nephrol., 19, 1721 (2008); Toba, K. et al.: Prog. Brain Res., 119, 337 (1998); Berrada, K. et al.: J. Biol. Chem., 275, 27229 (2000);<br></p>Formula:C46H65N13O12S2·xC2H4O2Color and Shape:White SolidMolecular weight:1056.23 + (60.05)x(S)-Hydroperoxy Des(boric Acid) Bortezomib
CAS:Controlled Product<p>Applications (S,S)-Hydroperoxy Des(boric Acid) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);<br></p>Formula:C19H24N4O4Color and Shape:NeatMolecular weight:372.42Cyclosporin AM 4N
CAS:Controlled ProductFormula:C61H109N11O12Color and Shape:NeatMolecular weight:1188.58Trofinetide (>90%)
CAS:Controlled Product<p>Applications Trofinetide is a synthetic analogue of the endogenous N-terminus tripeptide, Glycine-Proline-Glutamate (GPE), that has shown to be neuroprotective in animal models of brain injury.<br>References Wei, H.H. et al.: J Neuroinflammation. 2009 Aug 5;6:19.<br></p>Formula:C13H21N3O6Purity:>90%Color and Shape:NeatMolecular weight:315.32(S,S)-Hydroperoxy Des(boric Acid) Bortezomib
CAS:Controlled Product<p>Impurity Bortezomib USP Impurity L<br>Stability Unstable in Methanol<br>Applications (R)-Hydroperoxy Des(boric Acid) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);<br></p>Formula:C19H24N4O4Color and Shape:White To Off-WhiteMolecular weight:372.42N(1-(3-Methylbutanamido) N(1-Des(boric Acid)) Bortezomib
CAS:Controlled Product<p>Applications N(1-(3-Methylbutanamido) N(1-Des(boric Acid)) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);<br></p>Formula:C19H22N4O3Color and Shape:White To Off-WhiteMolecular weight:354.403(alphaR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetic Acid Salt
CAS:Controlled Product<p>Applications Bortezomib (B675700) intermediate. A boronic acid dipeptide derivative as proteasome inhibitors.<br>References Kisselev, A., et al.: Chem. Biol., 8, 739 (2001), Kisselev, A., et al.: J. Biol. Chem., 278, 35869 (2003), Verdoes, M., et al.: Chem. Biol., 13, 1217 (2006),<br></p>Formula:C15H28BNO2·C2HF3O2Color and Shape:NeatMolecular weight:379.225-Oxo-L-proline-d5
CAS:Controlled Product<p>Applications 5-Oxo-L-proline-d5 is a labelled cyclized derivative of L-Glutamic Acid (G596960). The pyroglutamate core has potential application for synthesis of novel anti-bacterials.<br>References Mischo A. et al.: ChemBioChem., 13, 1421 (2012); Angelov P. et al.: Org. Biomol. Chem.: 10, 3472 (2012);<br></p>Formula:C52H5H2NO3Color and Shape:White To Off-WhiteMolecular weight:134.14Lisinopril (8R,S)-Diketopiperazine (Mixture of Diastereomers)Mps1-IN-1 dihydrochloride
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Lisinopril (L468985) impurity.<br>References Drummer, O., et al.: Arzneim.-Forsch. Drug Res., 38, 647 (1988), Simpson, K., et al.: Drugs, 59, 1149 (2000),<br></p>Formula:C21H29N3O4Color and Shape:NeatMolecular weight:387.47(AlphaS)-3-[2-(2,6-Dimethylphenoxy)acetyl]-N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide
CAS:Controlled Product<p>Impurity Lopinavir EP Impurity R<br>Applications (αS)-3-[2-(2,6-Dimethylphenoxy)acetyl]-N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide (Lopinavir EP Impurity R) is an impurity of Lopinavir (L469480), a selective HIV protease inhibitor.<br>References Chitturi, S.R., et al.: J. Pharma. Biomed. Anal., 48, 1430 (2008); Devi, A.S.L., et al.: Magnet. Reson. Chem., 45, 424 (2007);<br></p>Formula:C47H58N4O7Color and Shape:NeatMolecular weight:791.0Deschloro-4’-chloro Clomiphene Hydrochloride
CAS:Controlled Product<p>Applications An impurity of Clomiphene (C587025).<br></p>Formula:C26H29Cl2NOColor and Shape:NeatMolecular weight:442.42t-Butyl 4-Bromobutanoate
CAS:Controlled Product<p>Applications t-Butyl 4-bromobutanoate is a useful research chemical for organic synthesis and other chemical and pharmaceutical processes.<br>References Brudeli, B., et al.: Bioorg. Med. Chem., 18, 8600 (2010); Colak, S., et al.: Macromolecules, 41, 8436 (2008)<br></p>Formula:C8H15BrO2Color and Shape:NeatMolecular weight:223.112-((4S,7S,10S,13S,15R)-10-Benzyl-15-hydroxy-7,13-diisobutyl-15-methyl-1-morpholino-2,5,8,11,14,18-hexaoxo-4-phenethyl-17-oxa-3,6,9,12-tetraazanonadecan-19-yl)-2-hydroxysuccinic Acid
<p>Applications 2-((4S,7S,10S,13S,15R)-10-Benzyl-15-hydroxy-7,13-diisobutyl-15-methyl-1-morpholino-2,5,8,11,14,18-hexaoxo-4-phenethyl-17-oxa-3,6,9,12-tetraazanonadecan-19-yl)-2-hydroxysuccinic Acid is an impurity of Carfilzomib (C183460), which is a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.<br>References Fostier, K., et al.: Oncotargets. Therap., 5, 237 (2012); Geurink, P.P., et al.: J. Med. Chem., 56, 1262 (2013); McCormack, P.L., et al.: Drugs., 72, 2023 (2012);<br></p>Formula:C46H65N5O14Color and Shape:White To Off-WhiteMolecular weight:912.033N-Nitroso-D,L-proline-d3
CAS:Controlled Product<p>Applications A labelled nitrosoamino acid with oncogenic activity.<br>References Nagasawa, H.T., et al.: J. Med. Chem., 16, 583 (1973)<br></p>Formula:C52H3H5N2O3Color and Shape:Off-WhiteMolecular weight:147.147Levothyroxine lactose adduct
<p>Levothyroxine is a drug product that is used for the treatment of hypothyroidism. It is an analog of thyroxine, which is synthesized in the thyroid gland. Levothyroxine has been chemically synthesized and contains a lactose adduct as an impurity standard. This drug product can be used to research metabolic pathways and metabolism studies with rats. Levothyroxine lactose adducts are used in natural products research and development, such as niche specialty drugs, due to their high purity standards. The CAS number for Levothyroxine lactose adduct is 266-072-3.</p>Formula:C27H31I4NO14Purity:85%MinMolecular weight:1,101.15 g/molN1.9,N1.9-Dimethyldesmopressin
<p>N1.9,N1.9-Dimethyldesmopressin is a synthetic analog of the natural hormone vasopressin. It is used as a drug product in research and development to study drug metabolism, but it has not been approved for use as a drug product by any regulatory agency. Impurities are determined by the USP or EP pharmacopoeia and are present at less than 1% or 2% respectively. The compound is synthesized through high purity chemical synthesis methods with purity greater than 99%.</p>Purity:Min. 95%[5-L-Aspartic Acid]-desmopressin
<p>Desmopressin is a synthetic drug that is used to treat diabetes insipidus and bleeding in patients who are on anticoagulants. It is also used as a diagnostic agent to distinguish between central and nephrogenic diabetes insipidus. Desmopressin is a peptide hormone with amino acid sequence L-Asp-D-Phe-L-Arg-L-Phe. It is synthesized by the combination of two amino acids, L-Aspartic Acid and L-Phenylalanine, which are then linked together through an amide bond. The synthesis of desmopressin occurs in two steps: first, the coupling of amino acid L-Aspartic Acid with the peptide linkage (N-[3-(2'-aminoethyl) carbonyl]glycine) to form the intermediate N-[3-(2'-Aminoethyl) carbonyl]-L-Aspartic Acid; second</p>Purity:Min. 95%Levothyroxine EP impurity B
CAS:<p>Please enquire for more information about Levothyroxine EP impurity B including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C15H11ClI3NO4Purity:Min. 95%Molecular weight:685.42 g/mol[4-L-Glutamic Acid]-desmopressin
<p>4-L-Glutamic Acid]-desmopressin is an analytical standard that is used to calibrate HPLC systems. This product is a high purity, synthetic, and drug development API impurity that can be used as a drug product or impurity standard. It is also available as an HPLC standard, niche, and custom synthesis. 4-L-Glutamic Acid]-desmopressin has been shown to have pharmacopoeia and CAS No.</p>Purity:Min. 95%(S)-3-((R)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid
CAS:<p>(S)-3-((R)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid is a drug product of the drug development industry. It is a metabolite of 3-(1,2,4-triazol-1-ylmethyl)thiazolidine-4-carboxylic acid and has been used as an analytical standard for HPLC methods. The compound has been shown to be naturally occurring in humans. (S)-3-(1,2,4-Triazol-1ylmethyl)thiazolidine 4 carboxylic acid is also used as the impurity standard for the API 3-(1,2,4 triazol 1ylmethyl)thiazolidine 4 carboxylic acid.</p>Formula:C9H12N2O4SPurity:Min. 95%Molecular weight:244.27 g/mol(R)-3-((R)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid
CAS:<p>(R)-3-((R)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid is a research and development, impurity standard, custom synthesis, drug product, synthetic, high purity, pharmacopoeia, drug development and analytical reagent. CAS No. 162148-17-6</p>Formula:C9H12N2O4SPurity:Min. 95%Molecular weight:244.27 g/molN-4,5[Acetylamino)methyl]desmopressin
<p>N-4,5[Acetylamino)methyl]desmopressin is a synthetic drug product that is used as an analytical standard for the identification and quantitation of desmopressin in pharmaceutical preparations. It is also used as an impurity standard for HPLC analysis. This product has been synthesized using a custom synthesis process, and has been shown to be suitable for use in drug development and research and development. N-4,5[Acetylamino)methyl]desmopressin is also available as a high purity HPLC standard that meets pharmacopoeia requirements.</p>Purity:Min. 95%Bortezomib impurity 76
CAS:<p>Bortezomib impurity 76 is an analytical reference material that is used in the development and production of pharmaceuticals. It is a high purity, HPLC standard for use as an impurity in the manufacture of bortezomib API. This material is a metabolite of bortezomib and it has been shown to be pharmacologically active. Bortezomib impurity 76 can also be used as an HPLC standard for drug product analysis.</p>Formula:C21H44BNO2Si2Purity:Min. 95%Color and Shape:PowderMolecular weight:409.56 g/molLisinopril diketopipirazine
CAS:<p>Lisinopril diketopipirazine is an analytical drug product. The CAS number for this product is 219677-82-4. This product requires a custom synthesis and impurity standard. It is synthesized from lisinopril hydrochloride and diketopiperazine hydrochloride. Lisinopril diketopipirazine is a high purity, pharmacopeia grade drug with a natural amino acid. This product has been used in research and development, niche markets, and drug development.</p>Formula:C21H29N3O4Purity:90%MinColor and Shape:White To Off-White SolidMolecular weight:387.47 g/mol[9-Glycine]desmopressin
<p>9-Glycine Desmopressin is a drug product that has been custom synthesized for use in research and development. This compound is an impurity standard that is used to identify the 9-glycine desmopressin impurities in the HPLC method. It is also used as a synthesis intermediate for the manufacture of the API. The CAS number for this compound is [CAS NO.]. This compound was manufactured using synthetic methods and has demonstrated high purity.</p>Purity:Min. 95%(S)-3-((S)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid
CAS:<p>(S)-3-((S)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid is a synthetic compound that is used as an impurity standard for HPLC. It is also used in drug development and research and development of pharmaceuticals. This product was made through custom synthesis and is not natural.</p>Formula:C9H12N2O4SPurity:Min. 95%Molecular weight:244.27 g/mol(5aR,10aR)-Tetrahydro-3H,5H,8H,10H-bisthiazolo[3,4-a:3',4'-d]pyrazine-5,10-dione
CAS:<p>(5aR,10aR)-Tetrahydro-3H,5H,8H,10H-bisthiazolo[3,4-a:3',4'-d]pyrazine-5,10-dione is a drug product that is an impurity standard for the API (Active Pharmaceutical Ingredient) 5α-tetrahydrospiro[benzofuran-1(3H),2'(3'H)]pyrido-[2,1'-cyclohexan]-6β,7β-(1'H)-dione. It is a metabolite of this API and can be used as a research and development analytical standard for HPLC. The CAS number for this compound is 72744-67-3. This substance has been found in natural products such as the seeds of Sesamum indicum L., Cucurbita maxima Duchesne var.</p>Formula:C8H10N2O42S2Purity:Min. 95%Molecular weight:870.29 g/molFelypressin acetate
CAS:<p>Felypressin acetate (PLV-2) is an agonist of vasopressin 1 and acts on all arginine vasopressin receptors 1AS.</p>Formula:C48H69N13O13S2Purity:97.06%Color and Shape:SolidMolecular weight:1100.27L-803087
CAS:<p>L-803087: potent sst4 receptor agonist, 0.7 nM Ki, 280x selectivity, boosts AMPA responses & seizures in mice.</p>Formula:C25H29F2N5O3Purity:97.58%Color and Shape:SolidMolecular weight:485.53Cetrorelix Acetate
CAS:<p>Cetrorelix Acetate is gonadotropin-releasing hormone (GnRH) receptor antagonist with an IC50 of 1.21 nM.</p>Formula:C70H92ClN17O14·xC2H4O2Purity:97.96%Color and Shape:SolidMolecular weight:1491.11(1S,2S)-Bortezomib
CAS:<p>(1S,2S)-Bortezomib (Bortezomib) is an enantiomer of Bortezomib.</p>Formula:C19H25BN4O4Purity:99.6%Color and Shape:SolidMolecular weight:384.24D-Ile-23-semaglutide trifluoroacetate
<p>D-Ile(23)-Semaglutide trifluoroacetate is a semaglutide impurity. The amino acid at position 23 has been replaced by the D-form of the amino acid D-isoleucine (D-Ile). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Purity:Min. 95%(5aS,10aS)-Tetrahydrodipyrrolo[1,2-a:1',2'-d]pyrazine-3,5,8,10(2H,5aH)-tetraone
CAS:<p>The objective of this project is to design a microcontroller-based system that can monitor and diagnose the level of damage in a composite material. The system will consist of an array of sensors, actuators, and microcontrollers that are connected by a wireless network. The sensors will measure the levels of damage at each point within the composite material. The actuators will provide feedback to the sensors, adjusting their frequency and amplitude based on the level of damage detected. Microcontrollers will be responsible for analyzing data from the sensors and diagnosing any faults in the system. A miniaturized dry skin patch could be used as an alternative to traditional wet skin tests for monitoring skin health.</p>Formula:C10H10N2O4Purity:Min. 95%Molecular weight:222.2 g/molMEDICA16
CAS:<p>MEDICA16: GPR40 agonist, GPR120 partial agonist, ATP-citrate lyase inhibitor, lowers TG, boosts insulin sensitivity in muscle.</p>Formula:C20H38O4Purity:99.62% - 99.87%Color and Shape:White SolidMolecular weight:342.51AZD-1656
CAS:<p>AZD-1656 is a glucokinase activator (GKA) that can cause dose-limiting hypoglycemia in normal animals used in embryofetal development studies and type 2</p>Formula:C24H26N6O5Purity:97.07% - 99.37%Color and Shape:SolidMolecular weight:478.5STAT3 degrader-2
CAS:<p>STAT3 Degrader-2 is a PROTAC-based compound that effectively reduces the total STAT3 protein levels, and is utilized in the research of cancer and various</p>Formula:C59H62N9O13PPurity:98%Color and Shape:SolidMolecular weight:1136.15(Iso)-MS4322
CAS:<p>(Iso)-MS4322 ((Iso)-YS43-22) is a protein arginine methyltransferase 5 (PRMT5 ) degrader with potential anticancer activity.</p>Formula:C55H76N10O12SPurity:99.05% - 99.79%Color and Shape:SolidMolecular weight:1101.32Duostatin 5
CAS:<p>Duostatin 5 (Duo-5) is a sea hare toxin analog commonly used in the synthesis of ADC compounds.</p>Formula:C40H69N9O6Purity:96.98%Color and Shape:SolidMolecular weight:772.03XY028-140
CAS:<p>XY028-140 is a selective CDK4/6 inhibitor and degrader, acting via PROTAC with ligands for Cereblon and CDK in cancer cells.</p>Formula:C39H40N10O7Purity:98.59%Color and Shape:SolidMolecular weight:760.8Reldesemtiv
CAS:<p>Reldesemtiv (CK-2127107) boosts exercise capacity, targeting fast muscle troponin, EC50 3.4 μM.</p>Formula:C19H18F2N6OPurity:97.27%Color and Shape:SolidMolecular weight:384.38C004019
CAS:<p>C004019 is a small molecule PROTAC capable of targeting tau for selective protein degradation from the cell, while recruiting tau and E3 ligase (Vhl) for</p>Formula:C49H70N12O9S2Purity:99.89%Color and Shape:SoildMolecular weight:1035.29Pidotimod diketopiperazine-6-propanoic acid
CAS:<p>Pidotimod is an impurity in the drug product, which is a synthetic diketopiperazine-6-propanoic acid. Pidotimod is an impurity standard that is used in the development of drugs and as a pharmacopoeia. It has been shown to be metabolized by human liver microsomes and human erythrocytes.</p>Formula:C9H12N2O4SPurity:Min. 95%Molecular weight:244.27 g/mol[Trp(O)25]-Semaglutide
<p>Semaglutide impurity.</p>Formula:C187H291N45O60Molecular weight:4,129.64 g/molLGD-6972
CAS:<p>LGD-6972 is an antagonist of glucagon receptor.</p>Formula:C43H46N2O5SPurity:98.8% - 99.62%Color and Shape:SolidMolecular weight:702.9AMG 837 calcium hydrate
CAS:<p>AMG 837 calcium hydrate is a potent GPR40 agonist with an EC50 of 13 nM.</p>Formula:C52H44CaF6O8Purity:98.07%Color and Shape:SolidMolecular weight:950.97Marizomib
CAS:<p>Marizomib is a novel irreversible brain-permeable proteasome inhibitor that inhibits CT-L, CT-T-laspase-like, and trypsin-like 20S proteasomes.Cost-effective and quality-assured.</p>Formula:C15H20ClNO4Purity:98.03% - 99.41%Color and Shape:SolidMolecular weight:313.78(2S,4S)-Sacubitril
CAS:<p>(2S,4S)-Sacubitril (Sacubitril Impurity C) is a stereoisomer derived from Sacubitril which is a potent NEP inhibitor.</p>Formula:C24H29NO5Purity:98%Color and Shape:SolidMolecular weight:411.49FK-565
CAS:<p>FK-565 is a ligand of nucleotide-binding oligomerization domain-1 (NOD1) that induces a mouse model of arteritis.</p>Formula:C22H38N4O9Color and Shape:SolidMolecular weight:502.559Pateamine A
CAS:<p>Pateamine A: marine-sourced macrolide from Mycale hentscheli; anticancer, antiviral, and translation inhibitor.</p>Formula:C31H45N3O4SColor and Shape:SolidMolecular weight:555.77c-Kit-IN-7
CAS:<p>c-Kit-IN-7 (compound 104) serves as an effective inhibitor of c-Kit, exhibiting an IC50 of 10 nM or less. It plays a crucial role in cancer research.</p>Formula:C27H32FN7O3Color and Shape:SolidMolecular weight:521.59PIN1 ligand-2
CAS:<p>PIN1ligand-2 (Intermediate M6) is a ligand designed for PROTAC target proteins (Ligands for Target Protein for s). It can be utilized in the synthesis of PROTACT(Rac)-P1D-34.</p>Formula:C15H25ClN2O6SColor and Shape:SolidMolecular weight:396.887SSTR5 antagonist 6
CAS:<p>SSTR5 antagonist 6, an orally active antagonist specific to the somatostatin receptor subtype 5 (SSTR5), exhibits an IC50 value of 24 nM. This compound is utilized in researching type 2 diabetes [1].</p>Formula:C22H28ClN3O4Color and Shape:SolidMolecular weight:433.93(S)-dHTC1
CAS:<p>(S)-dHTC1 is a molecular glue degrader specifically targeting the transcriptional coactivator ENL. It exhibits high affinity binding to E3 ligase only upon formation of the ENL:(S)-dHTC1 complex, with an IC50 of 93 nM. In MV4;11 cells, (S)-dHTC1 degrades ENL with a DC50 of 26 nM. This compound can be utilized for acute myeloid leukemia research.</p>Formula:C33H40N8O6SColor and Shape:SolidMolecular weight:676.786Tabimorelin hemifumarate
CAS:<p>orally active ghrelin receptor (GHS-R1a) agonist</p>Formula:C32H40N403C4H404Purity:98%Color and Shape:SolidMolecular weight:586.72L-796778 acetate
CAS:<p>L-796778 acetate is a selective sst3 receptor agonist. In CHO-K1 cells expressing hsst3 receptors, it acts as a partial agonist that inhibits Forskolin-induced cAMP production, with an IC50 value of 18 nM. Additionally, L-796778 acetate exhibits anticonvulsant properties.</p>Formula:C31H44N6O9Color and Shape:SolidMolecular weight:644.716[D-Ser]-Leuprolide (5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-D-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide)
CAS:<p>Lactams, nesoi</p>Formula:C59H84N16O12Color and Shape:Off-White PowderMolecular weight:1208.64546[MetO18]-Teriparatide
<p>Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoi</p>Formula:C181H291N55O52S2Color and Shape:Off-White PowderMolecular weight:4131.12586[Asp]5-Oxytocin (L-cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-aspartyl-L-cysteinyl-L-prolyl-L-leucyl-glycinamide)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C43H65N11O13S2Color and Shape:Off-White PowderMolecular weight:1007.42047[MetO8,18]-Teriparatide
CAS:<p>Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoi</p>Formula:C181H291N55O53S2Color and Shape:Off-White SolidMolecular weight:4147.12077Glucagon (HUMAN)
CAS:<p>Polypeptide, protein and glycoprotein hormones, their derivatives and structural analogues, nesoi</p>Formula:C153H225N43O49SColor and Shape:White PowderMolecular weight:3480.6157[D-His]-Leuprolide (5-Oxo-L-prolyl-D-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide)
CAS:<p>Lactams, nesoi</p>Formula:C59H84N16O12Color and Shape:Off-White PowderMolecular weight:1208.64546Cyclosporin H
CAS:<p>Lactams, nesoi</p>Formula:C62H111N11O12Color and Shape:White Off-White SolidMolecular weight:1201.84137[Cys(Ac)]1-Oxytocin (N-Acetyl-L-cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic (1-->6)-disulfide)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C45H68N12O13S2Color and Shape:Off-White PowderMolecular weight:1049.23Anti-Parallel Dimer-Oxytocin (Bis(L-cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide) cyclic (1-->6'),(6-->1')-bis(disulfide))
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C86H132N24O24S4Color and Shape:Off-White PowderMolecular weight:2014.39Insulin Human (COLD SHIPMENT REQUIRED) (DISCONTINUED)
CAS:<p>Insulin and its salts</p>Formula:C257H383N65O77S6Color and Shape:White CrystalsMolecular weight:5803.63765Parallel Dimer-Oxytocin (Bis(L-cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide) cyclic (1-->1'),(6-->6')-bis(disulfide))
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C86H132N24O24S4Color and Shape:Off-White PowderMolecular weight:2012.87292[O1(Ac)]8-Octreotide (D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(2R,3R)-1-acetoxy-3-hydroxybutan-2-yl]-L-cysteinamide cyclic (2-->7)-disulfide)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C51H68N10O11S2Color and Shape:Off-White PowderMolecular weight:1060.45105[Glu]4-Oxytocin (L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutamyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic (1->6)-disulfide)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C43H65N11O13S2Color and Shape:Off-White PowderMolecular weight:1008.18Isocyclosporin A
CAS:<p>Lactams, nesoi</p>Formula:C62H111N11O12Color and Shape:White Off-White PowderMolecular weight:1201.84137Parallel Dimer-Octreotide (Bis{D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-L-cysteinamide} cyclic (2-->2'),(7-->7')-bis(disulfide))
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C98H132N20O20S4Color and Shape:Off-White PowderMolecular weight:2036.88096[L-Leu]6-Leuprolide (5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-L-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide)
CAS:<p>Lactams, nesoi</p>Formula:C59H84N16O12Color and Shape:Off-White PowderMolecular weight:1208.64546Octreotide Acetate
CAS:<p>Polypeptide, protein and glycoprotein hormones, their derivatives and structural analogues, nesoi</p>Formula:C49H66N10O10S2·xC2H4O2Color and Shape:White PowderMolecular weight:1018.44048[Pro(Ac)]1-Leuprolide (5-Oxo-N-acetyl-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide)
CAS:<p>Lactams, nesoi</p>Formula:C61H86N16O13Color and Shape:Off-White PowderMolecular weight:1250.65603[MetO8]-Teriparatide
<p>Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoi</p>Formula:C181H291N55O52S2Color and Shape:Off-White PowderMolecular weight:4133.77[Phe(Ac)]1-Octreotide (N-Acetyl-D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide cyclic (2-->7)-disulfide)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C51H68N10O11S2Color and Shape:Off-White PowderMolecular weight:1060.45105D-[Asp]5-Oxytocin (L-cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-D-aspartyl-L-cysteinyl-L-prolyl-L-leucyl-glycinamide)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C43H65N11O13S2Color and Shape:Off-White PowderMolecular weight:1007.42047[Ser(Ac)]4-Leuprolide (5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-N-acetyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide)
CAS:<p>Lactams, nesoi</p>Formula:C61H86N16O13Color and Shape:Off-White PowderMolecular weight:1250.65603[Lys(Ac)]5-Octreotide (D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-N6-acetyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide cyclic (2-->7)-disulfide)
CAS:<p>Polypeptide, protein and glycoprotein hormones, their derivatives and structural analogues, nesoi</p>Formula:C51H68N10O11S2Color and Shape:Off-White PowderMolecular weight:1061.28Ref: 4Z-S-082061
Discontinued productRef: 4Z-S-082031
Discontinued productRef: 4Z-PD-122011
Discontinued productRef: 4Z-PI-119040
Discontinued productRef: 4Z-H-042016
Discontinued productRef: 4Z-A-7587
Discontinued productPROTAC MDM2 Degrader-1
CAS:<p>PROTAC MDM2 Degrader-1 uses PROTAC tech to break down MDM2 with an inhibitor, linker, and E3 ligase ligand.</p>Formula:C74H84Cl4N10O13Purity:98%Color and Shape:SolidMolecular weight:1463.33Ref: 4Z-H-042017
Discontinued productRef: 4Z-S-082074
Discontinued productRef: 4Z-S-082114
Discontinued productRef: 4Z-PO-079024
Discontinued productRef: 4Z-H-046003
Discontinued productRef: 4Z-S-082110
Discontinued productRef: 4Z-PL-105049
Discontinued productRef: 4Z-S-082078
Discontinued productRef: 4Z-PV-095005
Discontinued productRef: 4Z-S-082115
Discontinued productHJM-561
CAS:<p>HJM-561 is a potent and selective EGFR PROTAC with oral bioavailability, capable of overcoming osimertinib-resistant EGFR triple mutations and demonstrating</p>Formula:C45H51ClN9O5PPurity:98%Color and Shape:SolidMolecular weight:864.37Ref: 4Z-PI-119002
Discontinued productRef: 4Z-B-119026
Discontinued productRef: 4Z-M-198006
Discontinued productRef: 4Z-M-198001
Discontinued productPROTAC MDM2 Degrader-2
CAS:<p>PROTAC MDM2 Degrader-2: A potent MDM2-targeting compound with PROTAC tech for E3 ligase-mediated degradation.</p>Formula:C70H76Cl4N10O12Purity:98%Color and Shape:SolidMolecular weight:1391.22
![N-[(1S)-2-Amino-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FA622540.webp&w=3840&q=75)
![4-(Phenylamino]-1-benzyl-4-piperidinecarboxylic Acid Methyl Ester](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FP307500.webp&w=3840&q=75)
![(S)-N-[1-(3-Hydroxy-3-methylbutanamido)-1-oxo-3-phenylpropan-2yl]pyrazine-2-carboxamide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FH805105.webp&w=3840&q=75)
![(AlphaS)-3-[2-(2,6-Dimethylphenoxy)acetyl]-N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD476505.webp&w=3840&q=75)
![[5-L-Aspartic Acid]-desmopressin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIA173260.webp&w=3840&q=75)
![[4-L-Glutamic Acid]-desmopressin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIG173261.webp&w=3840&q=75)
![N-4,5[Acetylamino)methyl]desmopressin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIA173214.webp&w=3840&q=75)
![[9-Glycine]desmopressin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIG173262.webp&w=3840&q=75)
![(5aR,10aR)-Tetrahydro-3H,5H,8H,10H-bisthiazolo[3,4-a:3',4'-d]pyrazine-5,10-dione](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIT145578.webp&w=3840&q=75)
![(5aS,10aS)-Tetrahydrodipyrrolo[1,2-a:1',2'-d]pyrazine-3,5,8,10(2H,5aH)-tetraone](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIT145577.webp&w=3840&q=75)
![[Trp(O)25]-Semaglutide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIS27853.webp&w=3840&q=75)
